Story perspectives

NHS Unveils Tirzepatide for Weight Management Rollout

9/5/2025

Summary

Story summary

The NHS is introducing tirzepatide in a new weight management initiative focused on holistic patient care.
The phased rollout started in June 2025 and will extend over 12 years, targeting patients with a BMI over 40.
Funding issues affect Integrated Care Boards (ICBs), with only nine of 42 boards supporting 70% of eligible patients.
This initiative supports the NHS's 10-Year Health Plan, emphasizing prevention and access to modern treatments.
The NHS Digital Weight Management program provides interim support for eligible patients during the transition.

1 of 1

Story summary

The NHS is introducing tirzepatide in a new weight management initiative focused on holistic patient care.
The phased rollout started in June 2025 and will extend over 12 years, targeting patients with a BMI over 40.
Funding issues affect Integrated Care Boards (ICBs), with only nine of 42 boards supporting 70% of eligible patients.
This initiative supports the NHS's 10-Year Health Plan, emphasizing prevention and access to modern treatments.
The NHS Digital Weight Management program provides interim support for eligible patients during the transition.